Nearly one in four cancer drug packs in the NPPA’s revised price list will see no reduction in MRP, even as the overall average cut across ...

Prices of several anti-cancer drugs are set to fall significantly starting November 9, offering some financial relief. However, the prices ...

When a market is as jittery as it is right now, poor numbers are treated harshly. A new-age company in the business of buying and selling u...

If interest rates stay high, and there are signs of a slowdown, banks that depend on retail deposits are the ones to watch carefully. That ...

Tamil Nadu’s state-run TASMAC will make digital payments mandatory for liquor purchases exceeding Rs 1,000 from November 1. Customers can p...

Vivo's latest launch, the V80, is tailored for both photography lovers and general smartphone users, boasting a robust design, extended bat...

The Rs 30,213 crore IPO, priced between Rs 1,065 and Rs 1,119 per share, will remain open until October 23. At the upper end of the price b...

The much-anticipated Reliance Jio Platforms IPO is launching for public subscription starting October 21, 2023. Shareholders of Reliance In...

If FPI selling returns to the levels seen in April and May, financial sector stocks are the ones likely to be hit the most. This would be i...

Nifty gained 3% last week, forming a higher-top and higher-bottom structure, indicating bullish sentiment. Analysts suggest it must breach ...

India's National Pharmaceutical Pricing Authority has capped trade margins for 137 anti-cancer drugs at 30% of their maximum retail price. ...

For millions of cancer patients, the cost of treatment can be as frightening as the diagnosis. From steep markups to patented drugs that re...

Ralph Lauren has replaced its sustainability metric with AI metrics in its executive incentive plan for the year 2026. This change follows ...

Reliance Jio plans to launch its IPO with a unique bidding option exclusively for shareholders of Reliance Industries Limited. This special...

An expert group is finalizing the list of cancer medicines for a new trade margin cap. The government plans to implement a 30% cap to reduc...

The Supreme Court has asked the government to address high markups on medicines and medical devices. The court questioned the decision to l...

The Supreme Court expressed its worry over the government's restriction of price control measures to only anti-cancer drugs, questioning wh...